PURPOSE: To record the practices for prevention and management of invasive candidiasis in the PICU and investigate the epidemiology of candidiasis and its outcome nationwide. METHODS: A multicenter national study among PICUs throughout Greece. A questionnaire referring to local practices of prevention and management of candidemia was filled in, and a retrospective study of episodes that occurred during 5 years was conducted in all seven Greek PICUs. RESULTS: Clinical practices regarding surveillance cultures, catheter replacement protocols and antibiotic use were similar, although the case mix differed. In all PICUs prophylactic antifungal treatment was administered in transplant and neutropenic oncology patients. Discrepancy existed between PICUs concerning the first-line antifungal agents and treatment duration of candidemia. Twenty-two candidemias were nationally recorded between 2005 and 2009 with a median incidence of 6.4 cases/1,000 admissions. Median age was 8.2 (0.3-16.6) years. Candida albicans was isolated in 45.4 % of episodes followed by Candida parapsilosis (22.7 %). Common findings were presence of central venous and urinary catheters as well as mechanical ventilation and administration of antibiotics with anti-anaerobic activity in almost all patients with candidemia. Total parenteral nutrition was administered to five (22.7 %) patients. Most of the patients had a chronic underlying disease; five were oncology patients, and two-thirds of those with candidemia were colonized with Candida spp. Lipid amphotericin B formulations were the predominant therapeutic choice (54.5 %). Thirty-day mortality was 18.2 %. CONCLUSION: This first national study adds information to the epidemiology of candidemia in critically ill children. In these special patients, candidemia has a relatively low incidence and tends toward non-albicans Candida preponderance.
PURPOSE: To record the practices for prevention and management of invasive candidiasis in the PICU and investigate the epidemiology of candidiasis and its outcome nationwide. METHODS: A multicenter national study among PICUs throughout Greece. A questionnaire referring to local practices of prevention and management of candidemia was filled in, and a retrospective study of episodes that occurred during 5 years was conducted in all seven Greek PICUs. RESULTS: Clinical practices regarding surveillance cultures, catheter replacement protocols and antibiotic use were similar, although the case mix differed. In all PICUs prophylactic antifungal treatment was administered in transplant and neutropenic oncologypatients. Discrepancy existed between PICUs concerning the first-line antifungal agents and treatment duration of candidemia. Twenty-two candidemias were nationally recorded between 2005 and 2009 with a median incidence of 6.4 cases/1,000 admissions. Median age was 8.2 (0.3-16.6) years. Candida albicans was isolated in 45.4 % of episodes followed by Candida parapsilosis (22.7 %). Common findings were presence of central venous and urinary catheters as well as mechanical ventilation and administration of antibiotics with anti-anaerobic activity in almost all patients with candidemia. Total parenteral nutrition was administered to five (22.7 %) patients. Most of the patients had a chronic underlying disease; five were oncology patients, and two-thirds of those with candidemia were colonized with Candida spp. Lipidamphotericin B formulations were the predominant therapeutic choice (54.5 %). Thirty-day mortality was 18.2 %. CONCLUSION: This first national study adds information to the epidemiology of candidemia in critically ill children. In these special patients, candidemia has a relatively low incidence and tends toward non-albicans Candida preponderance.
Authors: N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen Journal: Eur J Clin Microbiol Infect Dis Date: 2012-04-01 Impact factor: 3.267
Authors: Anna Maria Tortorano; Giovanna Dho; Anna Prigitano; Giuseppe Breda; Anna Grancini; Vincenzo Emmi; Caterina Cavanna; Giovanni Marino; Silvia Morero; Cristina Ossi; Giacomo Delvecchio; Marco Passera; Vitaliano Cusumano; Antonio David; Giuseppina Bonaccorso; Alberto Corona; Myriam Favaro; Chiara Vismara; Maria Graziella Garau; Susanna Falchi; Milvana R Tejada Journal: Mycoses Date: 2011-06-12 Impact factor: 4.377
Authors: Christopher C Blyth; Sharon C A Chen; Monica A Slavin; Carol Serena; Quoc Nguyen; Deborah Marriott; David Ellis; Wieland Meyer; Tania C Sorrell Journal: Pediatrics Date: 2009-05 Impact factor: 7.124
Authors: Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes Journal: Clin Infect Dis Date: 2003-08-14 Impact factor: 9.079
Authors: William J Steinbach; Emmanuel Roilides; David Berman; Jill A Hoffman; Andreas H Groll; Ibrahim Bin-Hussain; Debra L Palazzi; Elio Castagnola; Natasha Halasa; Aristea Velegraki; Christopher C Dvorak; Arunaloke Charkabarti; Lillian Sung; Lara Danziger-Isakov; Catherine Lachenauer; Antonio Arrieta; Katherine Knapp; Mark J Abzug; Christine Ziebold; Thomas Lehrnbecher; Lena Klingspor; Adilia Warris; Kateri Leckerman; Teresa Martling; Thomas J Walsh; Daniel K Benjamin; Theoklis E Zaoutis Journal: Pediatr Infect Dis J Date: 2012-12 Impact factor: 2.129
Authors: Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary Journal: Crit Care Med Date: 2009-05 Impact factor: 7.598
Authors: Matt S Zinter; Steven G DuBois; Aaron Spicer; Katherine Matthay; Anil Sapru Journal: Intensive Care Med Date: 2014-07-15 Impact factor: 17.440
Authors: Carlo Tascini; Francesco Sbrana; Gianluigi Cardinali; Andrea Ripoli; Alessandro Leonildi; Francesco Amadori; Francesco Menichetti Journal: Intensive Care Med Date: 2014-05-16 Impact factor: 17.440
Authors: Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser Journal: Clin Microbiol Rev Date: 2019-02-27 Impact factor: 26.132